A new class of carbamoylating agents based on the cyclosulfamide scaffold

The neutrophil-derived serine proteases human leukocyte elastase (HLE) and proteinase 3 (PR3) have been implicated in various inflammatory diseases such as pulmonary emphysema, chronic bronchitis, asthma, cystic fibrosis, rheumatoid arthritis, psoriasis, and others. Poor regulation of the activity o...

Full description

Bibliographic Details
Main Author: Yang, Qingliang
Other Authors: Groutas, William C.
Format: Others
Language:en_US
Published: 2007
Subjects:
Online Access:http://hdl.handle.net/10057/444
id ndltd-WICHITA-oai-soar.wichita.edu-10057-444
record_format oai_dc
spelling ndltd-WICHITA-oai-soar.wichita.edu-10057-4442013-04-19T20:59:45ZA new class of carbamoylating agents based on the cyclosulfamide scaffoldYang, QingliangElectronic dissertationsThe neutrophil-derived serine proteases human leukocyte elastase (HLE) and proteinase 3 (PR3) have been implicated in various inflammatory diseases such as pulmonary emphysema, chronic bronchitis, asthma, cystic fibrosis, rheumatoid arthritis, psoriasis, and others. Poor regulation of the activity of these enzymes by their endogenous protein inhibitors is believed to result in the degradation of the major components of intracellular matrix. Agents that function as potent and selective inhibitors of these enzymes are of potential therapeutic value. The research described herein was an attempt to design and synthesize a class of non-covalent inhibitors of HLE and PR3 based on the cyclosulfamide scaffold. However during the course of these studies a new class of covalent inhibitors of HLE was discovered.Thesis (M.S.)--Wichita State University, College of Liberal Arts and Sciences, Dept. of Chemistry."December 2006."Includes bibliographical references (leaves 34-37)Groutas, William C.2007-02-08T01:43:53Z2007-02-08T01:43:53Z2006-12Thesisviii, 37 leaves: ill., digital, PDF file.259235 bytesapplication/pdft06112http://hdl.handle.net/10057/444en_USCopyright Qingliang Yang, 2006. All rights reserved.
collection NDLTD
language en_US
format Others
sources NDLTD
topic Electronic dissertations
spellingShingle Electronic dissertations
Yang, Qingliang
A new class of carbamoylating agents based on the cyclosulfamide scaffold
description The neutrophil-derived serine proteases human leukocyte elastase (HLE) and proteinase 3 (PR3) have been implicated in various inflammatory diseases such as pulmonary emphysema, chronic bronchitis, asthma, cystic fibrosis, rheumatoid arthritis, psoriasis, and others. Poor regulation of the activity of these enzymes by their endogenous protein inhibitors is believed to result in the degradation of the major components of intracellular matrix. Agents that function as potent and selective inhibitors of these enzymes are of potential therapeutic value. The research described herein was an attempt to design and synthesize a class of non-covalent inhibitors of HLE and PR3 based on the cyclosulfamide scaffold. However during the course of these studies a new class of covalent inhibitors of HLE was discovered. === Thesis (M.S.)--Wichita State University, College of Liberal Arts and Sciences, Dept. of Chemistry. === "December 2006." === Includes bibliographical references (leaves 34-37)
author2 Groutas, William C.
author_facet Groutas, William C.
Yang, Qingliang
author Yang, Qingliang
author_sort Yang, Qingliang
title A new class of carbamoylating agents based on the cyclosulfamide scaffold
title_short A new class of carbamoylating agents based on the cyclosulfamide scaffold
title_full A new class of carbamoylating agents based on the cyclosulfamide scaffold
title_fullStr A new class of carbamoylating agents based on the cyclosulfamide scaffold
title_full_unstemmed A new class of carbamoylating agents based on the cyclosulfamide scaffold
title_sort new class of carbamoylating agents based on the cyclosulfamide scaffold
publishDate 2007
url http://hdl.handle.net/10057/444
work_keys_str_mv AT yangqingliang anewclassofcarbamoylatingagentsbasedonthecyclosulfamidescaffold
AT yangqingliang newclassofcarbamoylatingagentsbasedonthecyclosulfamidescaffold
_version_ 1716583182587920384